Riskpilot← Back to searchSign inGet full accessMediro AB
ABActiveOrg 5591420681Mäshult 1General medical practice activities · NACE 8621Est. 20171-4 employees
Revenue 2025
SEK 1,5M
+1% vs 2024
EBITDA margin
95.0%
-2% vs 2024
Equity ratio
70.5%
Financial strength
Net profit 2025
SEK 902K
+1% vs 2024
| Revenue | SEK 1,5M | +1% |
| EBITDA | SEK 1,5M | -2% |
| Net profit | SEK 902K | +1% |
| Total assets | SEK 2,7M | +43% |
| Equity | SEK 1,9M | +89% |
| Employees | — | — |
Legal name
Mediro AB
Org number
5591420681
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
22 december 2017
Share capital
SEK 50 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas ensam av Bengtsson, Jakob Erik Emanuel
Company purpose
Bolaget skall bedriva hälso- och sjukvård samt handel med sjukvårdsutrustning. Utbildning, utveckling och konsultverksamhet inom hälso- och sjukvård samt inom IT. Handel med värdepapper och fastighetsförvaltning samt med ovan förenlig verksamhet.
Address
Mäshult 1
Email
erikbengtsson.1991@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 141 | 1 518 | 1 538 |
| Staff expenses | — | — | — | −9 | −2 |
| EBITDA | — | −3 | 119 | 1 498 | 1 461 |
| Depreciation & amort. | −0 | −0 | −0 | — | — |
| EBIT | 0 | −3 | 119 | 1 498 | 1 461 |
| Net financials | — | — | — | 0 | 60 |
| Profit before tax | 0 | −3 | 90 | 1 124 | 1 139 |
| Tax | −0 | −0 | −18 | −232 | −236 |
| Net profit | 0 | −3 | 72 | 892 | 902 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 50 | 48 | 184 | 1 896 | 2 715 |
| Equity | 50 | 48 | 119 | 1 011 | 1 913 |
| Long-term debt | 0 | 0 | 0 | — | — |
| Short-term debt | 0 | 0 | 36 | 480 | 16 |
| Total debt | — | — | 36 | 480 | 16 |
EBITDA margin
95.0%
This company
15.8%
Market median
+501% vs market
20212025
Equity ratio
70.5%
This company
38.2%
Market median
+85% vs market
20212025
Return on equity
47.2%
This company
18.4%
Market median
+157% vs market
20212025
Net profit margin
58.7%
This company
8.1%
Market median
+625% vs market
20212025
Asset turnover
0.57×
This company
1.12×
Market median
-49% vs market
20212025
Debt / equity
0.42×
This company
0.62×
Market median
+32% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2025 | |
| Board of Directors | 2025 | |
| Board of Directors | 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Mediro AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jakob Erik Emanuel Bengtsson | Chairman | 0 companies |
| Greta Lena Erika Bengtsson | Board of Directors | 0 companies |
| Carl Tore Bengtsson | Board of Directors | 0 companies |